Avicularin
CAS No. 572-30-5
Avicularin( —— )
Catalog No. M18833 CAS No. 572-30-5
Avicularin exhibits anti-inflammatory activity through the suppression of ERK signaling pathway in LPS-stimulated RAW 264.7 macrophage cells.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 129 | In Stock |
|
10MG | 192 | In Stock |
|
25MG | 325 | In Stock |
|
50MG | 486 | In Stock |
|
100MG | Get Quote | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAvicularin
-
NoteResearch use only, not for human use.
-
Brief DescriptionAvicularin exhibits anti-inflammatory activity through the suppression of ERK signaling pathway in LPS-stimulated RAW 264.7 macrophage cells.
-
DescriptionAvicularin exhibits anti-inflammatory activity through the suppression of ERK signaling pathway in LPS-stimulated RAW 264.7 macrophage cells. Avicularin inhibits the accumulation of the intracellular lipids by decreasing C/EBPα-activated GLUT4-mediated glucose uptake in adipocytes and potently inhibiting fatty acid synthase.
-
In VitroCell Proliferation Assay Cell Line:Huh7 cells Concentration:25, 50, 100 μg/mL Incubation Time:12, 24, 36 and 48 h Result:Inhibited cell proliferation in a dose-dependent manner.Western Blot Analysis Cell Line:RAW 264.7 cells Concentration:10, 30, 100, 300 μM Incubation Time:1 h Result:Inhibited LPS-induced protein expression of iNOS and COX-2, release of pro-inflammatory cytokine IL-1β, degradation of cytosolic IκB, and phosphorylation of ERK.RT-PCR Cell Line:3T3-L1 cells Concentration:50 μM Incubation Time:6 days Result:Decreased PPARγ, C/EBPα, and aP2 mRNA levels approximately 28.7, 69.5, and 18.3%, respectively.
-
In VivoAnimal Model:ACLT (anterior cruciate ligament transection)-induced rats Dosage:0.5, 1, 2 mg/kg Administration:Injected into the articular cavity of the right knee, twice a week for 4 weeks.Result:Alleviated the tibial subchondral osteolysis, reduces bone loss, and increases the bone mass of tibial subchondral bone.Attenuated ECM degradation, the loss of Aggrecan and Collagen II in ACLT-induced rats. Decreased the MMP3 and MMP13 protein level. Animal Model:Rats with amyloid Beta-induced Alzheimer's disease Dosage:25, 50, and 100 mg/kg Administration:Oral administration, for 21 days Result:Enhanced cognition activity, and reversed the effects of amyloid beta-induced inflammatory response and excessive oxidative stress.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorERK
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number572-30-5
-
Formula Weight434.35
-
Molecular FormulaC20H18O11
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (230.23 mM)
-
SMILESC1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)OC4C(C(C(O4)CO)O)O)O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
PRX-08066 Maleic aci...
PRX-08066 Maleic acid is a selective 5-HT2B receptor antagonist with IC50 of 3.4 nM, prevents the severity of pulmonary arterial hypertension in the MCT rat model. Phase 2.
-
PXS-5153A
PXS-5153A is an effective, selective, and fast-acting inhibitor of lysyl oxidase like 2/3 enzymes with enzymatic activity almost entirely blocked within 15 minutes. PXS-5153A could reduce crosslinks and ameliorates fibrosis.
-
Arazine
Arazine can be a a substrate for isoprenylcysteine methyltransferase by competing with prenylated G protein or its receptors site. Arazine is a cell-permeable modulator of G protein and GPCR signaling.